Zoetis Inc. (ZTS)
NYSE: ZTS · Real-Time Price · USD
118.65
-1.76 (-1.46%)
At close: Dec 5, 2025, 4:00 PM EST
118.80
+0.15 (0.13%)
After-hours: Dec 5, 2025, 7:58 PM EST
Zoetis Employees
Zoetis had 13,800 employees as of December 31, 2024. The number of employees decreased by 300 or -2.13% compared to the previous year.
Employees
13,800
Change (1Y)
-300
Growth (1Y)
-2.13%
Revenue / Employee
$680,942
Profits / Employee
$192,101
Market Cap
52.29B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 13,800 | -300 | -2.13% |
| Dec 31, 2023 | 14,100 | 300 | 2.17% |
| Dec 31, 2022 | 13,800 | 1,700 | 14.05% |
| Dec 31, 2021 | 12,100 | 800 | 7.08% |
| Dec 31, 2020 | 11,300 | 700 | 6.60% |
| Dec 31, 2019 | 10,600 | 600 | 6.00% |
| Dec 31, 2018 | 10,000 | 800 | 8.70% |
| Dec 31, 2017 | 9,200 | 200 | 2.22% |
| Dec 31, 2016 | 9,000 | 0 | - |
| Dec 31, 2015 | 9,000 | -1,000 | -10.00% |
| Dec 31, 2014 | 10,000 | 200 | 2.04% |
| Dec 31, 2013 | 9,800 | 500 | 5.38% |
| Dec 31, 2012 | 9,300 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
ZTS News
- 22 hours ago - Zoetis Receives Health Canada Approval for Portela™(relfovetmab injection) to Alleviate Pain Associated with Osteoarthritis in Cats - Business Wire
- 1 day ago - Zoetis Inc. (ZTS) Presents at Piper Sandler 37th Annual Healthcare Conference Transcript - Seeking Alpha
- 3 days ago - Zoetis Inc. (ZTS) Discusses R&D Pipeline Progress and Strategic Vision in Animal Health Innovation Transcript - Seeking Alpha
- 3 days ago - Zoetis Highlights R&D Leadership and Long-Term Growth Opportunity at Innovation Webcast - Business Wire
- 4 days ago - Top 15 High-Growth Dividend Stocks For December 2025 - Seeking Alpha
- 5 days ago - 2 Stocks to Buy Near Their 52-Week Lows - The Motley Fool
- 9 days ago - Zoetis Receives European Commission Marketing Authorization for Lenivia® (izenivetmab) to Reduce Pain Associated with Osteoarthritis (OA) in Dogs - Business Wire
- 14 days ago - Zoetis Osteoarthritis Pain Franchise Needs A Reset: Analyst - Benzinga